UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Public Service Enterprise Group
PEG
$38.2B
| $92.3M | 0.09% |
2,262,904
+105,171
| +5% | +$4.08M |
|
252
Sempra
SRE
$57.9B
| $91.7M | 0.09% |
1,751,532
+191,156
| +12% | +$9.49M |
|
|
NBL
253
DELISTED
Noble Energy, Inc.
NBL
| $91.7M | 0.09% |
1,183,358
+39,877
| +3% | +$2.9M |
|
254
Cardinal Health
CAH
$53.9B
| $89.9M | 0.09% |
1,311,681
-88,759
| -6% | -$6.04M |
|
255
TE Connectivity
TEL
$59.6B
| $89.9M | 0.09% |
1,454,059
+29,501
| +2% | +$1.77M |
|
256
Kinder Morgan
KMI
$71.7B
| $89.3M | 0.09% |
2,464,008
-280,353
| -10% | -$9.46M |
|
|
XLNX
257
DELISTED
Xilinx Inc
XLNX
| $88.2M | 0.09% |
1,863,966
+76,205
| +4% | +$3.67M |
|
258
Paychex
PAYX
$41.6B
| $86.9M | 0.09% |
2,090,881
-504
| -0% | -$20.7K |
|
259
Humana
HUM
$43.7B
| $86.3M | 0.09% |
675,991
-8,440
| -1% | -$1,000K |
|
260
MDU Resources
MDU
$4.17B
| $86.1M | 0.09% |
6,450,516
+507,073
| +9% | +$6.62M |
|
261
Stryker
SYK
$125B
| $85.9M | 0.09% |
1,018,433
+27,861
| +3% | +$2.28M |
|
262
Best Buy
BBY
$18.2B
| $84.4M | 0.09% |
2,721,198
+1,132,453
| +71% | +$30.5M |
|
263
AutoZone
AZO
$49.2B
| $83.8M | 0.08% |
156,329
-1,406
| -0.9% | -$744K |
|
|
RAI
264
DELISTED
Reynolds American Inc
RAI
| $83.8M | 0.08% |
2,776,964
-392,286
| -12% | -$11.3M |
|
265
Cencora
COR
$60.6B
| $83.7M | 0.08% |
1,151,982
+92,125
| +9% | +$6.31M |
|
266
International Paper
IP
$21.6B
| $82.7M | 0.08% |
1,754,136
-69,057
| -4% | -$3.03M |
|
267
Ameriprise Financial
AMP
$48.3B
| $82.5M | 0.08% |
687,493
-49,919
| -7% | -$5.58M |
|
268
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.71B
| – | – |
0
| – | – |
|
269
Netflix
NFLX
$299B
| $81M | 0.08% |
12,873,070
+1,001,210
| +8% | +$5.42M |
|
270
Seagate
STX
$194B
| $80.9M | 0.08% |
1,424,546
+18,790
| +1% | +$1.01M |
|
|
FRX
271
DELISTED
FOREST LABORATORIES INC
FRX
| $80.9M | 0.08% |
816,955
-289,424
| -26% | -$27M |
|
272
Franklin Resources
BEN
$17.6B
| $80.6M | 0.08% |
1,393,072
-123,162
| -8% | -$6.74M |
|
|
MHFI
273
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $80.2M | 0.08% |
966,392
-62,426
| -6% | -$4.92M |
|
|
GGP
274
DELISTED
GGP Inc.
GGP
| $79.5M | 0.08% |
3,375,021
+316,707
| +10% | +$7.36M |
|
275
Western Digital
WDC
$188B
| $79.3M | 0.08% |
1,136,846
+98,615
| +9% | +$6.61M |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.